Curaleaf Laboratories Launches First Certified Liquid Medical Cannabis Inhaler for UK Patients

The Curaleaf Que Medical Inhalation Device offers precise and consistent administration of cannabis-based medicines 1st September 2025 – Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, the device offers patients a precise, discreet, […]
Curaleaf Laboratories partners with Dalgety Ltd to distribute UK-grown EU-GMP medical cannabis flowers

Curaleaf Laboratories can today announce a partnership agreement has been reached with Dalgety Ltd, to exclusively manufacture and distribute medical cannabis API produced from their state-of-the-art cultivation facility in the UK. Dalgety, based in Derbyshire, are the first domestic cultivator of medical cannabis to hold EU-GMP licenses for the cultivation and supply of medical cannabis […]
Curaleaf Laboratories partners with ECS Botanics for exclusive distribution of dried flower range of medical cannabis in the UK

Rokshaw can today announce an exclusive distribution partnership agreement has been reached with ECS Botanics, a leading pharmaceutical manufacturer of medical cannabis based in Australia, for their supply of their EU-GMP range of products. This partnership grants exclusive distribution of three strains of dried EU-GMP medical cannabis flowers in the UK market, widening the collective […]
Launch of First Medical Cannabis Flower Grown in the British Isles, in Partnership with KHIRON Europe

Rokshaw can today announce the launch of KHIRON Europe’s new medical cannabis flower, the first medical cannabis flower grown in the British Isles, exclusively distributed from our MHRA-approved facility. The medical cannabis flower product is cultivated in Jersey in the Channel Islands under strict EU-GMP compliant conditions. The first batch of UK-grown medical cannabis flower […]
Launch of Four20 Pharma Medical Cannabis Range

Rokshaw can today announce the exclusive UK manufacture and distribution of medical cannabis products, under the Four20 Pharma brand. In line with market growth and patient demand, Rokshaw have bolstered its extensive range of medical cannabis, supplying Four20 Pharma products now available for private prescription in the UK. Originating from Germany, Four20 Pharma have a […]
Extending Our Range of UK Manufactured Medical Cannabis Flower

Rokshaw Laboratories can today announce the launch of our second medical cannabis flower product, manufactured in our MHRA approved manufacturing facility in Sunderland. After responding to clinical and patient feedback, Rokshaw can now manufacture a new strain of medical cannabis flower giving another option that can be considered for prescription by a specialist prescriber. In […]
The First UK Manufacturer of Medical Cannabis Flower

Rokshaw Laboratories can today announce the launch of the first UK range of medical cannabis flower, manufactured in our MHRA approved manufacturing facility in Sunderland. Ensuring the highest level of product quality, Rokshaw is now able to manufacture a full range of medical cannabis flower, in addition to our current full spectrum oil range, to […]